Tomorrow's specialists meet today's experts | Tijdens ISA2015 zijn in de PACE-studio gesprekken opgenomen, waarin Nederlandse arts-onderzoekers internationale experts interviewden over hun expertise.
ZIe ook www.pace-cme.org.

Nabil Seidah discovered the PCSK9 protein. He discusses the advances in the field since its discovery in 2002 with Gilles Lambert, who studies the biological function of PCSK9 and Jean-Claude Tardif, who presented what human genetics can tell us about the potential benefit of PCSK9-inhibiting therapy.
They share their experience with Nick van Es (AMC Amsterdam, The Netherlands) and Lotte Koopal (UMC Utrecht, The Netherlands).

Topics covered:
- The biology of PCSK9 in humans: Just LDL-cholesterol or more?
- Genetic variation at the PCSK9 locus: A contributor to CV risk?
- The PCSK9 protein: A key modulator of cardiovascular outcome

Participating Speakers:
- Gilles Lambert (University of Nantes Medical School, Nantes, France)
- Jean-Claude Tardif (Canadian Institutes of Health Research, Montréal, Canada)
- Nabil Seidah (Laboratory of Biochemical Neuroendocrinology, Montréal, Canada)